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Transformation by oncogenic Ras profoundly alters actin cytoskeleton organization. We investi-
gated Ras-dependent signaling pathways involved in cytoskeleton disruption by transfecting
normal rat kidney (NRK) cells with different Ras mutants. RasV12S35, a mutant known to activate
specifically the Raf/MAPK pathway, led to stress fiber and focal contact disruption, whereas the
adherens junctions remained intact. Next, we found that pharmacological inhibition of MEK was
sufficient to restore the cytoskeletal defects of ras-transformed NRK cells, including assembly of
stress fibers and focal contacts, but it did not induce reorganization of the cell-cell junctions.
Investigating the mechanism underlying this phenotypic reversion, we found that the sustained
MAPK signaling resulting from Ras-transformation down-regulated the expression of ROCKI and
Rho-kinase, two-Rho effectors required for stress fiber formation, at the post-transcriptional level.
On MEK inhibition, ROCKI/Rho-kinase expression and cofilin phosphorylation were increased,
demonstrating that the Rho-kinase/LIM-kinase/cofilin pathway was functionally restored. Fi-
nally, using dominant negative or constitutively active mutants, we demonstrated that expression
of ROCKI/Rho-kinase was both necessary and sufficient to promote cytoskeleton reorganization
in NRK/ras cells. These findings further establish the Ras/MAPK pathway as the critical pathway
involved in cytoskeleton disruption during Ras-transformation, and they suggest a new mecha-
nism, involving alteration in ROCKI/Rho-kinase expression, by which oncogenic Ras can specif-
ically target the actin-based cytoskeleton and achieve morphological transformation of the cells.
INTRODUCTION
Oncogenic transformation is characterized not only by de-
regulated growth control but also by pronounced morpho-
logical changes resulting from alterations in the organization
of the actin cytoskeleton and adhesive interactions. Changes
in the organization of actin filaments are highly correlated
with anchorage-independent growth and tumorigenicity,
suggesting a fundamental role for actin fibers in cell growth
control (reviewed in Pawlak and Helfman, 2001). Alterations
in actin filament structure are associated with decreased
expression of numerous cytoskeletal proteins (Button et al.,
1995). Forced re-expression of these proteins by transfection,
including -actinin (Gluck et al., 1993; Nikolopoulos et al.,
2000), profilin (Janke et al., 2000), vinculin (Rodriguez-Fer-
nandez et al., 1992), and tropomyosin (Prasad et al., 1993,
1999; Takenaga and Masuda, 1994; Gimona et al., 1996;
Braverman et al., 1996; Janssen and Mier, 1997) can reduce or
abrogate the transformed phenotype. Although the mecha-
nisms by which these proteins contribute to growth control
remain to be fully elucidated, these studies demonstrate that
changes in the expression of specific structural components
of the actin cytoskeleton can contribute to transformation.
Small GTPases of the Ras superfamily control a wide
spectrum of cellular processes by switching between inac-
tive GDP- and active GTP-bound states. When bound to
GTP, these proteins regulate cell behavior by binding to
effector molecules and by altering their localization, protein-
protein interactions, and activity. Small GTPase proteins can
be divided into subfamilies as follows: members of the Ras
subfamily regulate cell proliferation and differentiation,
whereas members of the Rho subfamily were first identified
as regulators of the actin cytoskeleton but also affect gene
expression and proliferation (Bar-Sagi and Hall, 2000). The
importance of the Ras subfamily of genes in the control of
cell proliferation is demonstrated by the high frequency of
mutations, among the highest of any gene in human cancers,
that activate Ras in tumors (Hunter, 1997). Ras is known to
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activate multiple effectors, including Raf, which in turn ac-
tivates the mitogen-activated protein kinase kinase (MEK)
and mitogen-activated protein kinase (MAPK) cascade, the
phosphatidylinositol 3-kinase (PI 3-K), and the RalGDS fam-
ily of guanine nucleotide exchange factors for Ral GTPases
(Katz and McCormick, 1997). A major task is to discern
which effector pathway contributes to which aspect of the
transformed phenotype (Shields et al., 2000).
In addition to structural components such as tropomyo-
sins (TM), organization of actin filaments is under the con-
trol of the Rho subfamily of small GTPases: Rho, Rac, and
Cdc42 (Bishop and Hall, 2000). Among these, Rho regulates
the assembly of actin stress fibers and focal contacts through
activation of the downstream effectors mDia and the closely
related kinases ROCKI/Rho-kinase (Amano et al., 1997; Wa-
tanabe et al., 1999). Activation of Rho-kinase by Rho is im-
plicated in stress fiber and in focal contact formation (Leung
et al., 1996; Amano et al., 1997). Rho-kinase increases the
phosphorylation of myosin light chains and thus increases
acto-myosin–based contractility, by directly phosphorylat-
ing myosin light chains and by negatively regulating myosin
phosphatase (Kureishi et al., 1997; reviewed in Fukata et al.,
2001). The resulting contractile forces are thought to contrib-
ute to the formation of stress fibers and focal contacts (Burr-
idge et al. 1997, Helfman et al., 1999). Rho-kinase also acti-
vates LIM-kinase, which subsequently phosphorylates
cofilin and thereby inhibits its actin-depolymerizing activity,
thus contributing to actin fiber stabilization (Yang et al.,
1998; Maekawa et al., 1999; Bamburg et al., 1999; Ohashi et al.,
2000).
Rho-dependent signaling is required for transformation
by oncogenic Ras (Khosravi-Far et al., 1995; Qiu et al., 1995;
Zhong et al., 1997). Although Rho activation is known to
promote the development of stress fibers and focal contacts,
Ras-transformed fibroblasts generally exhibit a loss of these
structural elements characteristic of Rho activity. These re-
sults have led to the interpretation that Rho activity may be
reduced in Ras-transformed cells. Accordingly, activated
Rho can restore stress fibers in Ras-transformed Rat1 fibro-
blasts, suggesting that Rho can be inactivated in these Ras-
transformed cells (Izawa et al., 1998). By contrast, inhibition
of Rho-kinase was shown to block Ras transformation in
NIH3T3 cells (Sahai et al., 1999) and to attenuate invasive-
ness of tumor cells (Itoh et al., 1999). Thus, the relationship
between Ras- and Rho-dependent signaling pathways dur-
ing transformation is still unclear.
Application of MEK inhibitors was reported to cause mor-
phological reversion of Ras-transformed fibroblasts (Fuka-
zawa and Uehara, 2000; Reuveni et al., 2000). The signaling
events associated with this phenotypic reversion, however,
have not been fully investigated. In the present study, we
have investigated the signaling pathways activated by Ras,
as well as the mechanism by which oncogenic Ras can
specifically target the actin-based cytoskeleton and thereby
achieve morphological transformation of the cells.
MATERIALS AND METHODS
Antibodies and Reagents
The mouse monoclonal anti-vinculin, anti--actin, anti–c-myc
(clone 9E10), and anti-tropomyosin (TM) (clone TM311) antibodies
(mAbs), as well as the rabbit polyclonal anti- catenin antibody,
were purchased from Sigma Chemical (St. Louis, MO). The mouse
anti-Rho-kinase and anti-ROCKI mAbs were obtained from Trans-
duction Laboratories (Lexington, KY). The mouse antiphosphory-
lated MAPK (Tyr204) mAb and the rabbit polyclonal anti-MAPK
were from Santa Cruz Biotechnology (Santa Cruz, CA). The rabbit
polyclonal anticofilin was from Cytoskeleton (Denver, CO). The
rabbit serum recognizing cofilin when phosphorylated by LIM-
kinase was kindly provided by J. R. Bamburg (Colorado State
University, Fort Collins, CO). The rabbit polyclonal antiphospho-
Akt (Ser473) was from Cell Signaling Technology (Beverly, MA).
The mAb 12CA5 to the HA tag was produced and purified by the
Antibody Facility of Cold Spring Harbor Laboratory (Cold Spring
Harbor, NY). Secondary antibodies Cy3-conjugated goat anti-mouse
and goat anti-rabbit IgG were purchased from Jackson ImmunoRe-
search Laboratories (West Grove, PA). Oregon green-conjugated
phalloidin was from Molecular Probes (Eugene, OR). PD098059,
U0126, and LY294002 were from Calbiochem (La Jolla, CA), and
Yoshitomi Pharmaceutical Industries (Osaka, Japan) kindly pro-
vided Y27632. All chemicals and reagents were obtained from
Sigma, unless otherwise indicated, and all tissue culture reagents
were from Life Technologies (Gaithersburg, MD).
Cell Culture and Drug Treatments
Normal and v-Ki-ras–transformed normal rat kidney (NRK) cells
were from ATCC (NRK ATCC CRL 1570 and 1569, respectively).
Cells were maintained in DMEM containing 5% FBS, 100 U/ml
penicillin, and 100 g/ml streptomycin in a humidified air (5%
CO2) atmosphere, at 37°C. Cells from subconfluent dishes were
treated with DMSO alone or with various concentrations of
PD098059, U0126, LY294002, or Y27632 (all prepared as 50 mM
stock in DMSO and stored at 20°C) before being fixed for immu-
nofluorescence or lysed for Western blotting or RNA extraction.
Expression Vectors and Transient and Stable
Transfections
Plasmids pDCR-Ha-Ras (G12V, T35S), pDCR-Ha-Ras (G12V, Y40C),
and pDCR-Ha-Ras (G12V, E37G), in which HA-tagged Ras proteins
were expressed under the control of CMV promoter were a gener-
ous gift of M. A. White (University of Texas, Southwestern Medical
Center, Dallas, TX). pEF-BOS-myc-Rho-kinase-CAT and pEF-BOS-
myc-Rho-kinase-RB/PH(TT) constructs, encoding myc-tagged mu-
tants of Rho-kinase, were kindly provided by K. Kaibuchi (Nara
Institute of Science and Technology, Nara, Japan). For stable expres-
sion of the Ras effector loop mutants, NRK cells were transfected by
the calcium phosphate procedure. Transfected cells were selected in
G418-containing medium (500 g/ml) for 2 weeks, and drug-resis-
tant colonies were pooled and analyzed, as described in RESULTS.
For transient transfections, cells were grown on glass coverslips in
DMEM containing 5% FBS. After 1 day of culture, cells were trans-
fected with plasmid DNA with Lipofectamine PLUS reagent (Life
Technologies) according to the manufacturer’s protocol. At 20 h
post-transfection, cells were eventually treated with DMSO,
PD098059, or U0126 for 30 h or with Y27632 for 1 h. Coverslips were
then fixed and stained for immunofluorescence.
Immunofluorescence
Cells grown on glass coverslips were fixed with 3% paraformalde-
hyde for 15 min, permeabilized with 0.2% Triton X-100 in PBS for 15
min, then blocked for 30 min with 1% BSA at room temperature.
Incubations with primary antibodies against vinculin (1:400), TM
(1:100), -catenin (1:500), HA-tag (1:800), or myc-tag (1:500) were
conducted at room temperature for 1 h. After washing, cells were
incubated with Cy3-conjugated secondary antibodies (1:500) for 45
min. To stain actin, fixed cells were incubated with Oregon green-
conjugated phalloidin. Cells were finally stained with 46-dia-
midino-2-phenylindole (DAPI), and coverslips were mounted using
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Prolong Antifade (Molecular Probes). Samples were examined and
pictures acquired on a Zeiss Axiophot microscope equipped with a
Photometrics SenSys (Oberkochen, Germany) cooled CCD camera
using Image 2.0.5 software (Oncor, Gaithersburg, MD). All photo-
graphs were taken at the same magnification.
Western Blot
Control and treated cells were washed with ice-cold PBS containing
1 mM sodium orthovanadate before direct extraction in 2% SDS
Laemmli sample buffer. Lysates were clarified by centrifugation
(16,000 g, 15 min at 4°C), and protein concentrations were measured
by bicinchoninic acid protein assay (Bio-Rad, Hercules, CA). Equal
amounts of proteins were resolved by SDS-PAGE and were trans-
ferred to nitrocellulose membrane (Schleicher & Schuell, Keene,
NH). The membrane was blocked in 5% nonfat dried milk or 2%
BSA in Tris-buffered saline plus 0.1% Tween 20 and incubated with
primary antibodies for 1 h, followed by incubation with appropriate
horseradish peroxidase-conjugated secondary antibodies for 1 h at
room temperature. Immunoreactive bands were detected by chemi-
luminescence (NEN, Boston, MA), according to the manufacturer’s
instructions.
Rho-GTP Pull-down Assay
Measurement of GTP-bound Rho was performed using the Rho
Activation Assay kit (Upstate Biotechnology), following the manu-
facter’s instructions. Briefly, the RhoA-binding domain of Rhotekin
expressed as a GST-fusion protein was used to affinity precipitate
GTP-bound Rho from cells lysed in 50 mM Tris, pH 7.2, 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 500 mM NaCl, 10 mM
MgCl2 and a cocktail of protease inhibitors (Roche). Precipitated
Rho-GTP was then detected by immunoblot analysis, using a poly-
clonal anti-Rho (-A, -B, -C) antibody (Upstate Biotechnology).
Figure 1. Activation of the Ras/MAPK pathway disrupts the actin cytoskeleton and focal contacts in NRK cells. NRK cells were transfected
with cDNAs encoding various mutant forms of Ras or empty vector (pDCR). G418-resistant clones were pooled and grown onto coverslips
for immunofluorescence staining, or extracts were prepared for Western blotting. (A) Whole-cell extracts from NRK/pDCR, NRK/
RasV12S35, NRK/RasV12C40, and NRK/RasV12G37 cells were immunoblotted with mAb 12CA5 (recognizing the HA tag) and anti--actin
to ensure equal loading. The same lysates were analyzed with antiphospho-MAPK (pMAPK) or antiphospho-Akt (pAkt) antibodies. (B) NRK
cells grown on glass coverslips were fixed. Actin stress fibers and focal contacts were visualized by indirect immunofluorescence using
phalloidin and antivinculin mAb, respectively. Bar, 20 m. (C) NRK/RasV12S35 cells were treated with 0.1% DMSO or 50 M PD098059 for
48h, then fixed and stained with phalloidin and antivinculin mAb. Bar, 20 m.
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Semiquantitative RT-PCR
Total RNAs were extracted with Trizol reagent (Life Technologies).
cDNA synthesis and PCR amplification were performed with Su-
perscript One-Step RT-PCR (Life Technologies), using 0.2 g RNA.
Rho-kinase cDNAs were amplified with sense primer (5-ATGTC-
GACTGGGGACAGTTTTGAGACT) and antisense primer (5-
CTATAGATTTCTTCTTTGATTTCCCTC) for 15, 20, and 25 cycles,
to remain within the exponential phase of amplification. As an
internal control, rat GAPDH cDNA was also amplified with sense
primer (5-GTTCCAGTATGATTCTACCCACGG) and antisense
primer (5-ATGAGCCCTTCCACGATGCCAAAG). Ten-microliter
aliquots of the PCR reaction were size-separated on a 2% agarose
gel, photographed, and analyzed by densitometry using AlphaIm-
ager 2200 v5.5 software (Alpha Innotech Corp., San Leandro, CA).
RESULTS
Constitutive Activation of the Ras/MAPK Pathway
Is Sufficient to Disrupt the Actin Cytoskeleton in
NRK Cells
Whereas untransformed NRK cells have a flat morphology
and well-developed stress fibers, NRK/ras cells (rat fibro-
blasts transformed by v-Ki-ras) are round and are devoid of
stress fibers and focal contacts. To assess the relative contri-
bution of the various downstream effectors of Ras, we ana-
lyzed different Ras effector loop mutants for their ability to
induce cytoskeleton disruption in NRK cells. Untransformed
NRK cells were transfected with three different Ras effector
loop mutants: RasV12S35, which activates almost exclu-
sively the Raf pathway; RasV12C40, which activates exclu-
sively the PI 3-K pathway; and RasV12G37, which activates
RalGDS (White et al., 1995). Stable cell lines were established
for each construct. Expression and specificity of the trans-
fected constructs were confirmed by Western-blot analysis
using antibodies to the HA epitope tag, active phospho-
MAPK, which is downstream of Raf, and phospho-Akt,
which is downstream of PI 3-K. Figure 1A shows that
RasV12S35 increased only MAPK phosphorylation, whereas
RasV12C40 increased only Akt phosphorylation. RasV12G37
had no activatory effect on either kinase, confirming that this
mutant does not activate either pathway.
Among the different cell lines, the NRK/RasV12S35 cells
exhibited spindle-shape morphology and grew in multiple
layers. The distribution of actin filaments and vinculin was
examined by indirect immunofluorescence (Figure 1B). This
analysis showed that the actin cytoskeleton and focal con-
tacts were disrupted in NRK/RasV12S35 cells. In contrast,
both the NRK/RasV12C40 and NRK/RasV12G37 cell lines
retained organized stress fibers and abundant cell-matrix
contacts characteristic of control NRK cells (Figure 1B). To
further demonstrate that activation of a MEK-dependent
pathway was responsible for the observed loss of actin fibers
and focal contact, NRK/RasV12S35 cells were treated with
50 M of the MEK inhibitor PD098059 (Dudley et al., 1995).
This treatment leads to restoration of stress fibers and focal
contacts (Figure 1C). These results demonstrate that activa-
Figure 2. Reorganization of the actin cytoskeleton in NRK/ras cells upon treatment with PD098059. NRK/ras cells were treated with 0.1%
DMSO (a) or 50 M PD098059 for 10 h (b), 24 h (c), 48 h (d), or 72 h (e), then fixed and stained with Oregon green-conjugated phalloidin.
Untransformed NRK cells are shown in (f) for comparison. Bar, 20 m.
Oncogenic Ras Inhibits Rho-kinase
Vol. 13, January 2002 339
tion of the Ras/MAPK pathway is both necessary and suf-
ficient to disrupt actin stress fibers and focal contacts in NRK
cells.
Inhibition of MEK Restores Actin Cytoskeleton
Organization and Focal Contact Assembly in Ras-
transformed NRK Cells
We next tested whether inhibition of the Ras/MAPK path-
way could reverse the phenotype of NRK cells transformed
by a fully activated oncogenic Ras (NRK/ras cells). We
found that NRK/ras cells treated for 24 h with 50 M
PD098059 reacquired a fibroblastic morphology and formed
a flat, nonoverlapping monolayer. To examine cytoskeletal
changes associated with this morphological reversion, actin
was stained with fluorescence-labeled phalloidin. Stress fi-
bers are noticeably absent from NRK/ras cells compared
with the well-developed actin bundles observed in untrans-
formed NRK cells (Figure 2a, compared with 2f). On treat-
ment with PD098059, actin organization changed from
patches in rounded cells (Figure 2a) to a diffuse network in
flat cells (10 h, Figure 2b) and then to cortical fibers sur-
rounding cells with a more polarized morphology (24 h,
Figure 2c). After 48 h of PD098059 treatment, actin filaments
were reorganized into stress fibers extending through the
entire cellular body (Figure 2d). Bundling of actin eventually
increased further at 72 h, thus resembling stress fibers of
untransformed NRK cells (Figure 2e, compared with 2f).
Ras-transformed NRK cells also exhibit disrupted focal
contacts. Immunofluorescence labeling with anti-vinculin
antibodies showed that NRK cells contained well-developed
focal contacts, whereas the vinculin staining in NRK/ras
cells exhibited a diffuse cytoplasmic pattern (Figure 3). A
Western-blot analysis showed that the level of expression of
vinculin was not affected in NRK/ras cells. Treatment of
NRK/ras cells with 50 M PD098059 for 48 h led to the
assembly of vinculin-containing focal contacts (Figure 3).
These focal contacts were almost indistinguishable from
those of control NRK cells. This result suggests that consti-
tutive activation of MEK prevents the assembly of focal
contacts and that inhibition of MEK is sufficient to reverse
this effect.
To eliminate the possibility that PD098059 may restore
actin stress fibers and focal contacts by acting on targets
other than MEK1/2, we used the unrelated MEK inhibitor
U0126 (Favata et al., 1998). Consistent with the effects being
MEK-dependent, treatment of NRK/ras cells with 25 M of
U0126 led to effects similar to those of PD098059.
Alterations in actin filament structure are correlated with
decreased expression of numerous cytoskeletal proteins
(Button et al., 1995). It was previously shown that Ras-
transformed NRK cells have substantially reduced levels of
high-molecular-weight TM isoforms (Matsumura et al.,
1983). Because these actin-associated proteins are involved
in stabilization of the actin cytoskeleton, we asked whether
restoration of stress fibers in cells treated with MEK inhibi-
tors was associated with changes in the level of TM expres-
sion level. Treatment of NRK/ras cells by either 50 M
PD098059 or 25 M U0126 for 48 h specifically enhanced
TM-1 expression (Figure 4). The expression level of TM-2
was not affected. Immunofluorescence staining showed that
the TM-1 was incorporated into the newly assembled stress
fibers (our unpublished results). Taken together, these re-
sults demonstrate that the Ras/MAPK pathway plays a
pivotal role in the regulation of actin cytoskeleton organiza-
tion in Ras-transformed NRK cells.
The Ras/MAPK Pathway Is Not Implicated in Cell-
Cell Contact Disruption
Transformation of NRK cells by Ras also resulted in the
disruption of -catenin containing cell-cell contacts. Immu-
nofluorescence labeling with anti--catenin showed that
NRK cells formed strong cell-cell junctions, whereas NRK/
Figure 3. Assembly of focal
contacts in NRK/ras cells treated
with PD098059. NRK and NRK/
ras cells are compared with
NRK/ras cells treated with 50
M PD098059 for 48 h. Fixed
cells were stained with anti-vin-
culin mAb, followed by Cy3-con-
jugated antimouse antibody. Bar,
20 m.
Figure 4. MEK inhibition causes elevation of TM-1 expression level.
Whole cell extracts of NRK and NRK/ras cells maintained in the
absence () or presence () of 50 M PD098059 or 25 M U0126 for
48 h were immunoblotted using anti-TM or anti--actin antibodies.
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ras cells showed only a faint and diffuse staining (Figure
5A). The addition of PD098059 for 48 h did not restore
-catenin distribution in NRK/ras cells (Figure 5A). Further
treatments with PD098059 or U0126 at various concentra-
tions, for various times, failed to restore -catenin–contain-
ing cell-cell contacts, suggesting that MEK does not play a
role in the distribution of -catenin in NRK/ras cells. Con-
sistently, NRK/RasV12S35 cells still exhibited -catenin–
containing cell-cell contacts (Figure 5A) despite a strong
activation of MEK in these cells, as shown by the constitutive
phosphorylation of MAPK (see Figure 1A). In addition to
monitoring the localization and assembly of -catenin into
cell-cell contacts, we measured its expression level by immu-
noblotting. Consistent with the immunofluorescence data, Fig-
ure 5B shows a down-regulation of -catenin expression in
NRK/ras cells that was not restored upon MEK inhibition. The
expression level of -catenin in NRK/RasV12S35 cells was
shown to be normal compared with that of NRK cells (Figure
Figure 5. Activation of the Ras/MAPK pathway is not implicated
in -catenin–containing cell-cell junction disruption. NRK, NRK/
ras, and NRK/RasV12S35 cells were treated with DMSO, PD098059,
or U0126, then fixed and stained for immunofluorescence or lysed
for Western blot analysis. (A) Cells were treated with 0.1% DMSO
(control) or 50 M PD098059 for 48 h and fixed. Cell-cell junctions
were visualized using anti–-catenin antibody, whereas nuclei were
stained with DAPI. Bar, 20 m. (B) Whole-cell extracts of cells
maintained in the absence () or presence () of 50 M PD098059
or 25 M U0126 for 48 h were immunoblotted using anti-–catenin
or anti-–actin antibodies.
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5B). These results suggest that the Ras/MAPK pathway spe-
cifically targets stress fibers and focal contacts during transfor-
mation of NRK cells by Ras but is not implicated or not suffi-
cient to disrupt cell-cell junctions.
ROCKI/Rho-Kinase Signaling Is Compromised in
NRK/ras Cells and Is Restored Upon MEK
Inhibition by a Posttranscriptional Mechanism
The Rho family of small GTPases, Rho, Rac, and Cdc42,
plays a central role in regulating actin organization through
downstream effectors, which activities are controlled by in-
teractions with active GTP-bound forms of the Rho family
(Bishop and Hall, 2000). ROCKI/Rho-kinase are serine/
threonine kinases involved in Rho-mediated actin reorgani-
zation, i.e., formation of stress fibers and focal contacts
(Leung et al., 1996; Amano et al., 1997). To examine whether
the morphological changes induced by MEK inhibitors were
accompanied by modifications in Rho activation, the activity
of endogenous RhoA was measured in NRK and NRK/ras
cells, using a pull-down assay that only capture the active
GTP-bound form of the GTPase (Ren et al., 1999). There was
little difference between Rho-GTP levels in parental versus
Ras-transformed cells, as well as between untreated versus
MEK inhibitor-treated cells (Figure 6A), demonstrating that
neither the loss of stress fibers in Ras-transformed cells nor
the restoration of stress fibers induced by MEK inhibitors
were associated with changes in Rho-GTP levels.
Despite normal levels of Rho-GTP, NRK/ras cells are
devoid of stress fibers, suggesting that Rho-GTP was no
longer coupled to formation of actin stress fibers in these
cells. Interestingly, we found that expression of both ROCKI
and Rho-kinase was greatly decreased in NRK/ras cells
compared with untransformed NRK cells (Figure 6B). On
treatment with PD098059 or U0126, Rho-kinase expression
returned to levels similar to that seen in NRK cells (Figure
6B). The levels of ROCKI and Rho-kinase were also exam-
ined in the Ras-effector mutant expressing cells, especially
the NRK/Ras V12S35 cell line. No changes were observed
compared with the control parental cells, suggesting that
activation of MEK is required but not sufficient to induce
down-regulation of ROCKI/Rho-kinase expression. ROCKI
and Rho-kinase activates LIM-kinase, which subsequently
phosphorylates cofilin and thereby inhibits its actin-depoly-
merizing activity (Yang et al., 1998; Maekawa et al., 1999;
Bamburg et al., 1999; Ohashi et al., 2000). Concomitant with
the restoration of Rho-kinase expression, we found that
cofilin phosphorylation was induced in NRK/ras cells upon
treatment with either MEK inhibitor, suggesting that the
Rho-kinase/LIM-kinase/cofilin pathway was functionally
restored (Figure 6B). Phosphorylation of the myosin light
chain, another target of ROCKI/Rho-kinase (Kureishi et al.,
1997; Fukata et al., 2001), was also increased upon ROCKI/
Rho-kinase expression up-regulation (our unpublished re-
sults).
We next examined whether down-regulation of Rho-ki-
nase in NRK/ras cells was controlled at the transcriptional
level. Rho-kinase mRNA levels in NRK and NRK/ras cells
were examined by semiquantitative RT-PCR analysis. As
shown in Figure 6C, steady-state levels of Rho-kinase
mRNA were similar in NRK and NRK/ras cells, suggesting
that the down-regulation of Rho-kinase expression in NRK/
Figure 6. Restoration of ROCKI/
Rho-kinase expression and activity
upon MEK inhibitor treatment of
NRK/ras cells. (A) NRK and
NRK/ras cells were maintained in
the absence () or presence () of
50 M PD098059 or 25 M U0126
for 48 h. Rho-GTP levels were then
analyzed (representative of two
experiments). (B) Cells were
treated as indicated, and whole
cell extracts were immunoblotted
using anti-ROCKI, anti-Rho-ki-
nase, and anti--actin antibodies
(top panels). The same extracts
were probed with an antiphospho-
cofilin antibody, followed by anti-
cofilin antibody, after the mem-
brane was stripped (bottom
panels). (C) Rho-kinase mRNA ex-
pression in NRK and NRK/ras
cells upon treatment with
PD098059. Rho-kinase cDNAs
were amplified by PCR for 15, 20,
or 25 cycles from RNAs of NRK
and NRK/ras cells incubated in
the presence () or in the absence
() of 50 M PD098059 for 48 h.
As a control, rat GAPDH cDNA
was also amplified (top panel). Densitometry analysis of Rho-kinase cDNAs amplified for 20 cycles. Data are representative of three independent
experiments (mean SD). Relative Rho-kinase mRNA levels, normalized to GAPDH levels, are expressed vs. control NRK, which is arbitrarily set
to 100% (bottom panel).
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ras cells is controlled at the protein level. Up-regulation of
Rho-kinase expression in NRK/ras cells treated with
PD098059 also appeared to be regulated at the protein level,
because the Rho-kinase mRNA level did not change signif-
icantly upon treatment with PD098059 (Figure 6C).
ROCKI/Rho-Kinase Is Both Necessary and Sufficient to
Promote Assembly of Stress Fibers in NRK/ras Cells
To determine whether ROCKI/Rho-kinase was involved in the
morphological changes induced by inhibition of MEK in NRK/
ras cells, we used the specific ROCKI/Rho-kinase inhibitor
Y27632 (Kuwahara et al., 1999). Treatment of NRK/ras cells with
Y27632 had no effect on cell morphology (Figure 7), suggesting
that the low level of ROCKI/Rho-kinase expressed in NRK/ras
cells has no apparent role in maintaining their transformed mor-
phology. Stress fibers were induced in NRK/ras cells by treat-
ment with U0126 for 48 h, then cells were further incubated with
10 M Y27632 for 1 h. Inhibition of ROCKI/Rho-kinase resulted
in disassembly of stress fibers and focal contacts (Figure 7), sug-
gesting that formation of these structures was under the control of
a ROCKI/Rho-kinase–dependent pathway that was restored
upon MEK inhibition.
To further demonstrate the requirement for ROCKI/Rho-
kinase activity in the morphological reversion induced by MEK
Figure 8. Overexpression of a dominant-negative
Rho-kinase prevents assembly of stress fibers in
NRK/ras cells treated with MEK inhibitors. NRK/
ras cells were transiently transfected with pEF-Bos-
myc-Rho-kinase-RB/PH(TT). After 24 h, cells were
treated with 25 M U0126 for 30 h, then fixed. Actin
was stained as described in Figure 1. Note that non-
transfected cells (arrowhead) form stress fibers,
whereas Rho-kinase-RB/PH(TT)–transfected cells
(arrow) are devoid of stress fibers. Bar, 20 m.
Figure 7. Assembly of stress fibers in NRK/ras cells requires Rho-kinase activity. NRK/ras cells were treated with 0.1% DMSO or 25 M
U0126 for 48 h. Cells were then further incubated in the absence () or presence () of 10 M Y27632 for 1 h and fixed. Actin and vinculin
were labeled as described in Figure 1. Bar, 20 m.
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inhibitors, we expressed a dominant-negative form of Rho-
kinase, Rho-kinase-RB/PH(TT) (Amano et al., 1997). Consistent
with the decreased levels of Rho-kinase expression, NRK/ras
cells transfected with Rho-kinase-RB/PH(TT) in the absence of
MEK inhibitors showed essentially no change in morphology.
NRK/ras cells transfected with Rho-kinase-RB/PH(TT) were
then treated with PD098059 or U0126. This treatment failed to
restore stress fibers or focal contacts in the cells expressing the
dominant negative form of ROCKI/Rho-kinase (Figure 8). This
result demonstrates that elevation of Rho-kinase expression is
absolutely required for the restoration of actin fibers in NRK/
ras cells treated with MEK inhibitors.
Finally, we determined whether expression of Rho-kinase
was sufficient to reverse the Ras-transformed phenotype.
Transfection of NRK cells with a wild-type Rho-kinase pro-
duced thick stress fibers but had no effect in NRK/ras cells.
Expression of a constitutively active form of Rho-kinase,
Rho-kinase-CAT (Amano et al., 1997) in NRK/ras cells re-
stored the formation of stress fibers, unlike neighboring cells
that do not express the construct (Figure 9). The extent of the
reversion was only partial, however, because stress fibers
were very thick and cells did not spread, suggesting that
other pathways are cooperating with Rho-kinase to correctly
assemble actin fibers when NRK/ras cells are treated with
MEK inhibitors. Taken together, these results demonstrate
that Rho-kinase activity is both necessary and sufficient to
promote assembly of stress fibers and focal contacts in
NRK/ras cells.
DISCUSSION
Among the most striking manifestations of the transformed
phenotype are the severe disruption of the actin cytoskele-
ton and the loss of cell-matrix and cell-cell contacts fre-
quently associated with altered patterns of cytoskeletal pro-
tein expression. These cellular changes contribute directly to
the poor adhesiveness of transformed cells, their enhanced
motility, and their ability to grow in an anchorage-indepen-
dent manner (Hunter, 1997; Pawlak and Helfman, 2001). It is
therefore important to determine the molecular mechanisms
responsible for these cellular changes.
Oncogenic Ras has been shown to dramatically affect actin
organization, assembly of focal contacts, and the formation of
adherens junctions and tight junctions (Izawa et al., 1998; Po-
tempa and Ridley, 1998; Chen et al., 2000; Reuveni et al., 2000).
Ras is known to activate several signaling pathways and could,
in principle, exert its cytoskeletal effects via several distinct
pathways. PI 3-K was reported to be a Ras effector (Rodriguez-
Viciana et al., 1994), mediating signals from Ras to the actin
cytoskeleton (Rodriguez-Viciana et al., 1997) and to adherens
junctions (Potempa and Ridley, 1998). In this study, we show
that expression of the Ras mutant RasV12C40, which strongly
activates the PI 3-K pathway, was not sufficient to disrupt
stress fibers and focal contacts in NRK cells. In addition, inhi-
bition of PI 3-K by LY294002 or wortmannin failed to restore
actin microfilaments or focal contacts in NRK/ras cells, further
suggesting that activation of PI 3-K is not required for Ras-
induced disruption of the cytoskeleton in NRK cells.
The present study rather points to the MEK/MAPK path-
way as the main route mediating oncogenic Ras effects on
stress fibers and focal contacts. Several lines of evidence sup-
port this conclusion. First, transfection of the Ras mutant
RasV12S35, which selectively and strongly activates the Ras/
MAPK pathway, induces disruption of stress fibers and focal
contacts in untransformed NRK cells. Second, we showed that
application of two structurally unrelated MEK inhibitors,
namely PD098059 and U0126, induced complete recovery of
stress fibers in NRK/ras cells, with a concomitant assembly of
vinculin-containing focal contacts. Taken together, these results
strongly support the notion that the Ras/MAPK pathway is a
major pathway through which morphological transformation
occurs in these cells. Further support comes from a recent
report showing that the phenotypic reversion of Ras-trans-
formed Rat1 fibroblasts induced by the Ras farnesylation in-
hibitor HR12 is mediated by the Ras/MAPK pathway (Reuv-
eni et al., 2000).
Formation of adherens junctions is also dramatically affected
by oncogenic Ras, thus allowing transformed cells to migrate
(Potempa and Ridley, 1998; Reuveni et al., 2000). Reuveni et al.
(2000) showed that assembly of cell-cell junctions is restored in
Rat1/ras cells upon HR12 treatment, most likely through inhi-
bition of MEK. In our system, however, we demonstrated that
the Ras/MAPK pathway is not implicated in regulation of this
cellular structure. Application of MEK inhibitors did not re-
store -catenin–containing cell-cell contacts or -catenin ex-
pression in NRK/ras cells. In addition, untransformed NRK
Figure 9. Expression of constitutively active Rho-
kinase induces stress fibers in NRK/ras cells. NRK/
ras cells were transfected with pEF-Bos-myc-Rho-
kinase-CAT plasmid (Rho-kinase-CAT). Cells were
fixed 24 h after transfection and stained with phal-
loidin or myc antibodies as described in Figure 1.
Bar, 20 m.
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cells transfected with the RasV12S35 mutant retained expres-
sion of -catenin and correct localization at cell-cell junctions.
The divergent results between our study and the work of
Reuveni and colleagues (2000) may be due to differences in cell
types used in these studies (Rat1 vs. NRK) or type of transfor-
mation (Ha-ras vs. Ki-ras). Another possibility is that the ras-
farnesylation inhibitor HR12 used by Reuveni and colleagues
(2000) has a yet uncharacterized effect on another pathway
implicated in cell-cell junction regulation in addition to its
demonstrated effect as a MEK inhibitor. In epithelial MDCK
cells, activation of both MAPK and PI 3-K pathways by Ras is
required for cell-cell junction disassembly (Potempa and Rid-
ley, 1998). We tested this hypothesis in our model by treating
NRK/ras cells with PD098059 together with LY294002. This
treatment failed to restore cell-cell junctions (our unpublished
results), strengthening the fact that epithelial and fibroblastic
cells exhibit quite different phenotypes upon transformation by
Ras.
Altogether, our results demonstrate that in NRK/Ras cells,
organization of the actin-based cytoskeleton is mainly under
the control of the Ras/MAPK pathway. Although the mecha-
nism by which MEK or MAPK delivers the signal to the cy-
toskeleton is not fully understood, our results provide impor-
tant new insights. We found that activation of MEK in NRK/
ras cells induces alterations in ROCKI/Rho-kinase–dependent
pathways, which are implicated in actin stress fiber organiza-
tion without changes in the activation status of Rho. During the
preparation of this manuscript, a similar conclusion was
reached by Sahai et al. (2001) in Ras-transformed Swiss-3T3
cells. However, although Sahai et al. reported a modification in
the subcellular localization of ROCKI/Rho-kinase that is
thought to bring ROCKI/Rho-kinase away from its substrates,
we observed that NRK/ras cells have a greatly reduced level of
both ROCKI and Rho-kinase. This decreased expression was a
direct consequence of sustained MAPK signaling, because in-
hibition of MEK restored the expression of ROCKI/Rho-ki-
nase. We further demonstrated that ROCKI/Rho-kinase ex-
pression is controlled in NRK/ras cells at the protein level
(Figure 6). Although the most prominent role assigned to
MEK/MAPK activity is related to transcriptional regulation,
recent reports have suggested a role for this pathway in post-
transcriptional events related to cell adhesion. MEK was found
to localize to the cell periphery (Kranenburg et al., 1999), while
MAPK was shown to be targeted to focal contacts upon acti-
vation (Fincham et al., 2000). The translocation of MEK or
MAPK to focal contacts may then serve to direct specificity
toward appropriate downstream targets at cellular adhesion
(Fincham et al., 2000). Changes in the phosphorylation state of
cytoskeleton components may provide a regulatory mecha-
nism through which MAPK could affect cytoskeleton organi-
zation. To date, however, there are no reports of direct phos-
phorylation of ROCK/Rho-kinase by MEK/MAPK.
Interestingly, induction of calpain activity downstream of
MEK/MAPK was recently demonstrated in EGFR signaling
and this activation was linked to focal contacts disassembly
(Glading et al., 2000). Calpains also degrade Focal Adhesion
Kinase (FAK) upon transformation by v-Src (Carragher et al.,
2001). Based on these experiments, one could hypothesized
that MEK-induced activation of proteases such as calpains
could be implicated in ROCKI/Rho-kinase degradation during
Ras transformation.
Importantly, we demonstrated that not only expression of
ROCKI/Rho-kinase was restored but also its activity, because
we showed that phosphorylation of cofilin by LIM-kinase and
phosphorylation of myosin light chain were both induced
upon MEK inhibition. Phosphorylation of cofilin by LIMK
induces a stabilization of actin filaments through inhibition of
its actin-depolymerizing activity (Yang et al., 1998; Maekawa et
al., 1999; Bamburg et al., 1999; Ohashi et al., 2000), whereas the
phosphorylation of myosin light chains increases myosin ac-
tivity (Amano et al., 1996). Together, these events directly con-
tribute to the assembly of stress fibers (Bishop and Hall, 2000).
Conversely, suppression of these signaling pathways most
likely accounts for the loss of stress fibers in Ras-transformed
cells. We have also demonstrated that up-regulation of
ROCKI/Rho-kinase expression induced by MEK inhibition is
critical for the concomitant restoration of the actin cytoskeleton.
Both the ROCKI/Rho-kinase inhibitor Y27632, and a dominant
negative mutant of Rho-kinase, Rho-kinase-RB/PH(TT)
(Amano et al., 1997) abolished the effects of the PD098059
treatment, demonstrating that Rho-kinase is indeed required
for the process of actin stress fiber assembly and suggesting
that no other pathway can compensate for the defect in Rho-
kinase expression. Although previous studies have reported a
phenotypic reversion of ras-transformed cells upon PD098059
treatment, our study provides a molecular mechanism through
which this inhibitor acts.
These experiments prompted us to check whether overex-
pression of Rho-kinase in NRK/ras cells could be sufficient to
reverse their transformed phenotype. Expression of a wild-
type Rho-kinase failed to induce stress fibers, possibly because
the protein expressed by this exogenous construct is prone to
degradation like the endogenous Rho-kinase. A constitutively
active mutant of Rho-kinase was able to induce stress fibers in
NRK/ras cells, demonstrating that down-regulation of Rho-
kinase expression is a critical step for the acquisition of a
transformed phenotype during Ras transformation of NRK
cells. However, compared with the effect of MEK inhibitors,
this mutant fails to completely reverse cells to a normal mor-
phology, suggesting that other proteins cooperate with Rho-
kinase during PD098059-induced reversion. Rho-kinase is
thought to cooperate with an additional Rho effector, mDia, in
the control of stress fiber formation (Nakano et al., 1999; Wa-
tanabe et al., 1999). We do not know at this point, however,
whether mDia is affected by Ras-transformation of NRK cells.
Cellular transformation by Ras is associated with a marked
decrease in the expression of several actin-binding proteins
(Button et al., 1995), including high-molecular-weight TMs.
Alterations in TM expression seem to be central to the trans-
formed phenotype, because reexpression of these proteins can
reverse several aspects of the transformed phenotype, includ-
ing actin microfilament assembly, contact inhibition, and an-
chorage-dependent cell growth, but the underlying mecha-
nisms are incompletely understood (reviewed in Pawlak and
Helfman, 2001). Treatment of c-Jun–transformed FR3T3 rat
cells with PD098059 reversed down-regulation of TM-2 (Ljun-
dahl et al., 1998). By contrast, the ras-induced down-regulation
of TMs in NIH3T3-ras cells was found to be MEK independent,
because treatment with PD098059 had little effect on TM levels
(Janssen et al., 1998). Interestingly, we report here that inhibi-
tion of MEK in NRK/ras cells totally alleviated repression of
TM-1 expression, suggesting that the decreased TM-1 level
observed in NRK/ras cells is a direct result of Ras signaling
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pathway. TMs are actin-binding proteins know to protect actin
stress fibers from the action of severing proteins, such as gel-
solin (Ishikawa et al., 1989; Pittenger et al., 1994). It is thus likely
that TMs will cooperate with ROCKI/Rho-kinase to properly
assemble and stabilize the actin cytoskeleton during PD098059
treatment of NRK/ras cells. Obviously, the involvement of
other proteins that were not investigated in this study is not
excluded.
In summary, our results demonstrate that in NRK/Ras cells,
organization of the actin cytoskeleton is mainly under the
control of the Ras/MAPK pathway and that chronic activation
of this pathway during Ras transformation specifically targets
formation of stress fibers and focal contacts but is not impli-
cated in cell-cell junction regulation. Our study also provides a
mechanism, involving down-regulation of structural compo-
nents of the cytoskeleton and inhibition of ROCKI/Rho-ki-
nase–dependent pathways, by which oncogenic Ras can
achieve morphological transformation of the cells. Although
several studies have reported that Rho can cooperate with Ras
to transform cells (Khosravi-Far et al., 1995; Qiu et al., 1995;
Zhong et al., 1997), down-regulation of ROCKI/Rho-kinase
expression may represent a way to uncouple Rho from stress
fiber formation without affecting its other biological functions,
such as regulation of proliferation and migration (Olson et al.,
1998; Banyard et al., 2000). This would explain why Ras-trans-
formed cells generally exhibit a loss of stress fibers and focal
contacts, which are characteristic of Rho activity in normal
cells. Whether MAPK signals to the cytoskeleton directly by
phosphorylating cytoskeletal components and/or cytoskeleton
regulators, such as ROCKI/Rho-kinase, or indirectly by con-
trolling their protein levels through transcription, translation,
or degradation is under investigation.
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